Akhlesh Kumari | Pharmaceutical Chemistry | Best Researcher Award Β
Mrs. Akhlesh Kumari, IFTM University Moradabad, India
Mrs. Akhlesh Kumari ππ©βπ is a dedicated academician with 8 years of teaching experience and pursuing Ph.D. in Pharmaceutical Chemistry π. With an M. Pharm from Central University, Rajasthan π, she has published 4 research papers π and filed 3 patents π. Her research focuses on Pharmaceutical Chemistry π¬, contributing to the field’s advancement. Mrs. Kumari’s commitment to education and research makes her a promising figure in her field π. With a citation index of 13 π, she demonstrates her impact on the research community. Her work showcases her potential as a leading researcher π.
Publication Profile
Education
Mrs. Akhlesh Kumari is a dedicated academician with a strong background in pharmaceutical sciences π. With 8 years of teaching experience π, she has established herself as a knowledgeable educator. Currently, she is pursuing her Ph.D. from IFTM University, Moradabad, India π, further enhancing her expertise. She holds an M. Pharm degree in Pharmaceutical Chemistry from Central University, Rajasthan, India π«. Her academic pursuits demonstrate her commitment to advancing knowledge in her field π¬. With a passion for teaching and research, Mrs. Kumari is poised to make significant contributions to pharmaceutical sciences.
Professional Memberships
Mrs. Akhlesh Kumari’s professional affiliations are currently focused on her academic and research pursuits π. Although she doesn’t hold any specific professional memberships π€, her dedication to her field is evident through her teaching and research endeavors. As she continues to grow in her career, potential memberships in professional organizations could further enhance her networking opportunities and contributions to pharmaceutical sciences π. For now, her commitment to education and research remains a priority, driving her to make meaningful impacts in her field π¬.
Research Focus
Mrs. Akhlesh Kumari focuses her research on organic synthesis, particularly the development of heterocyclic compounds and transition metal-catalyzed reactions such as Ruthenium-catalyzed oxidative annulation. Her work explores the design of novel antimicrobial agents, including thymol-derived chalcones and benzotriazoles, integrating computational studies to understand structure-activity relationships. This research is crucial in the development of new pharmaceutical compounds with potential biological activity. Her studies bridge synthetic organic chemistry and medicinal chemistry, targeting antimicrobial resistance and innovative drug discovery strategies.